Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease
Completed · Not applicable
Conditions studied: Sickle Cell Disease
In brief
SCD is an inherited disorder of hemoglobin that affects over 100,000 Americans, most of whom live in low-resourced neighborhoods. Acute SCD complications result in 230,000 emergency department visits and $1.5 billion annually in acute-care expenditures. Prior research indicates that increased disease-specific knowledge correlates with improved clinical outcomes in SCD. Thus, targeting strategies to improve disease-specific knowledge is a high priority in the care of individuals with SCD. Significant evidence describes how educational materials, including online educational programs, can be used to increase disease-specific knowledge. In this study, the investigators will evaluate a mobile phone technology intervention based on the prior evidence that technologies can improve SCD-specific knowledge.
Key facts
- Study ID
- NCT03629678
- Run by
- Vanderbilt University Medical Center
- People needed
- 67
- Starts
- 2018-07-01
- Expected to finish
- 2023-07-01
- Last updated by the study team
- 2025-01-14
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- receives care at the community health clinic,
- diagnosis of SCD (Hgb SS, SC, Sβ-thal),
- ability to speak and understand written English
- has access to a smartphone or computer
- between 18-70 years.
You may not qualify if…
- lack of access to a smartphone or computer
- inability to speak and understand written English
Where it is running
- The Ohio State University Medical Center — Columbus, Ohio, United States
- Vanderbilt University — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.